A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Ireland's pharmaceutical industry shipped billions' worth of goods to the U.S., but face threats from Trump 2.0.

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...

and Zepbound. If you're new to Ro, they'll even give you a $50 credit good towards your treatment. It's completely free to use the Ro GLP-1 Insurance Checker, an invaluable tool that it can make ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Semaglutide (Wegovy and Ozempic): Originally developed for type 2 diabetes, this medication mimics the GLP-1 hormone, ...

Food companies are rushing to reformulate products for protein lovers. That’s a category that includes both people taking the powerful new class of obesity drugs known as GLP-1s, who are ...

Zepbound sales rose by 985% to $1.9 billion ... Management says it will be able to make 60% more tirzepatide in the first half of 2025 than it did in the same 2024 period. The company also ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

A new study breaks down several cases of Ozempic blindness, linked to semaglutide and tirzepatide. Here's what could be ...